Technology | Vascular Closure Devices | November 05, 2018

Cordis Launches Mynx Control Vascular Closure Device

November 2, 2018 — Cordis, a Cardinal Health company, today announced the U.S. launch of Mynx Control Vascular Closure Device (VCD). It integrates active extravascular sealing and bioresorbability properties with a next-generation delivery system to maximize predictability, safety, and ease of use in sealing 5-7 French femoral arterial access sites. Vascular closure devices reduce time to hemostasis and ambulation in patients who have undergone diagnostic or interventional procedures.
The Mynx Control VCD features a deployment system that is designed for predictable deployment and ease of use. It will be available in 5 French as well as 6/7 French sizes. Highlights of this new system include:
  • Sheath catch that is compatible with the procedural sheath;
  • Tension indicator that provides visual confirmation of device position for proper sealant deployment; and
  • Ergonomic handle with a 2-button deployment design to simplify procedural steps. 
Leveraging the MynxGrip VCD technology, which has been used in over 2 million interventional cases worldwide, the Mynx Control VCD utilizes a dual-mode active sealing mechanism. This allows the sealant to interlock with the contours of the arterial wall, expanding to fill the tissue tract and create a matrix structure for clot formation. With all closure components resorbing within 30 days, nothing is left behind. The Mynx VCD technology has shown it can to reduce surgical complications, expedite recovery, shorten hospital stays and increase patient comfort.[1-5]
For more information: cardinalhealth.com
 
References:
 

Related Content

News | Cath Lab

May 31, 2022 — Innovative Health, LLC, a specialty cardiology reprocessor, announced that the company has received ...

Home May 31, 2022
Home
News | Cath Lab

May 26, 2022 — The U.S. Food and Drug Administration (FDA) has recalled the Dragonfly OpStar Imaging Catheter, and has ...

Home May 26, 2022
Home
News | Cath Lab
April 25, 2022 – NewYork-Presbyterian Hudson Valley Hospital celebrated the launch of its interventional cardiology ...
Home April 25, 2022
Home
News | Cath Lab
April 18, 2022 – Royal Philips and Oulu University Hospital (Finland) have announced a strategic 10-year partnership ...
Home April 18, 2022
Home
News | Cath Lab
February 16, 2022 – Fremont Bank Foundation recently donated $750,000 to its community partner, St. Rose Hospital ...
Home February 16, 2022
Home
News | Cath Lab
February 14, 2022 — A collaborative effort between The Valley Heart and Vascular Institute’s cardiology team ...
Home February 14, 2022
Home
Sponsored Content | Videos | Cath Lab

Advancements in analytics and data visualizations are helping to streamline operations and improve productivity at cath ...

Home January 13, 2022
Home
News | Cath Lab

January 4, 2022 — The U.S. Food and Drug Administration (FDA) has authorized marketing of the first laser-based device ...

Home January 04, 2022
Home
News | Cath Lab

December 14, 2021 — RSIP Vision, a medical imaging company applying advanced artificial intelligence (AI) and computer ...

Home December 14, 2021
Home
Feature | Cath Lab

November 15, 2021 — RealView Imaging Ltd. recently received FDA 510(k) clearance for its Holoscope-i holographic system ...

Home November 15, 2021
Home
Subscribe Now